Sign In
Buy TRUMY
$14.18
+0.0800 (+0.567%)
At Close: Jun 03, 2026
Terumo (OTCMKTS:TRUMY) Shares Gap Down – Here’s Why
03:26am, Sunday, 22'nd Feb 2026
Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped down before the market opened on Friday. The stock had previously closed at $12.76, but opened at $12.1501. Terumo shares last trade
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
06:47am, Friday, 13'th Feb 2026
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
03:55am, Tuesday, 13'th Jan 2026
Terumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Comparing Utah Medical Products (NASDAQ:UTMD) and Terumo (OTCMKTS:TRUMY)
02:24am, Tuesday, 06'th Jan 2026
Terumo (OTCMKTS:TRUMY - Get Free Report) and Utah Medical Products (NASDAQ: UTMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses
Terumo (OTCMKTS:TRUMY) vs. TriSalus Life Sciences (NASDAQ:TLSI) Critical Survey
02:08am, Tuesday, 30'th Dec 2025
TriSalus Life Sciences (NASDAQ: TLSI - Get Free Report) and Terumo (OTCMKTS:TRUMY - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies base
BioLife Solutions (NASDAQ:BLFS) versus Terumo (OTCMKTS:TRUMY) Financial Review
03:17am, Thursday, 25'th Dec 2025
Terumo (OTCMKTS:TRUMY - Get Free Report) and BioLife Solutions (NASDAQ: BLFS - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses base
Brainsway (NASDAQ:BWAY) and Terumo (OTCMKTS:TRUMY) Critical Review
01:28am, Tuesday, 23'rd Dec 2025
Terumo (OTCMKTS:TRUMY - Get Free Report) and Brainsway (NASDAQ: BWAY - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the
Terumo Corporation (TRUMY) Q2 2026 Earnings Call Transcript
03:31pm, Wednesday, 12'th Nov 2025
Terumo Corporation (OTCPK:TRUMY) Q2 2026 Earnings Call November 12, 2025 3:00 AM EST Company Participants Jin Hagimoto - CFO, CIO, GM of Accounting, Corporate Planning, Tax, IT Planning Dept. & GBS Hi
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
08:00am, Thursday, 30'th Oct 2025
OXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd.
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
08:00am, Tuesday, 28'th Oct 2025
New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreement Terumo to pay a total of $30 million to Orchestra BioMed Orchestra BioMed
Terumo Corporation (TRUMF) Q1 2026 Earnings Call Transcript
12:52pm, Thursday, 07'th Aug 2025
Terumo Corporation (OTCPK:TRUMF) Q1 2026 Earnings Conference Call August 7, 2025 4:00 AM ET Company Participants Jin Hagimoto - CFO, CIO, GM of Accounting, Corporate Planning, Tax, IT Planning Dept. &
Terumo: Consistent Execution Continues To Drive Solid Growth Metrics
07:09pm, Wednesday, 21'st May 2025
Terumo continues to deliver solid financial results, with steady revenue growth and margin improvement, but share price performance has lagged the broader med-tech sector. The company's strengths lie
Terumo Corporation (TRUMF) Q4 2025 Earnings Call Transcript
03:12pm, Wednesday, 14'th May 2025
Terumo Corporation (OTCPK:TRUMF) Q4 2025 Results Conference Call May 14, 2025 4:00 AM ET Company Participants Jin Hagimoto - Chief Financial Officer Hikaru Samejima - President & Chief Executive Offic
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering.
Terumo Corporation (TRUMF) Q3 2025 Earnings Call Transcript
02:16pm, Friday, 14'th Feb 2025
Terumo Corporation (OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET Company Participants Jin Hagimoto – Chief Financial Officer Conference Call Participants Jin Hagimoto [
